Back

Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: Insights from the CREDENCE trial

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Congress committee e-posters choice in preventive cardiology and special populations Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Associate Professor Brendon Neuen

The George Institute for Global Health, Sydney (Australia)

36 More presentations in this session

Presentation thumbnail
Masters Athlete Screening Study (MASS): incidence of cardiovascular disease and major adverse cardiac events over five years of screening
Ms B. Morrison (Langley, CA)
Abstract Slides
Presentation thumbnail
Cardiopulmonary examinations of athletes returning to high-intensity sport activity following SARS-CoV-2 infection
Assistant Professor O. Kiss (Budapest, HU)
Abstract Slides
Presentation thumbnail
Exercise training induces benign right ventricular hypertrophy along with functional improvement and without pathological processes or arrhythmogenicity in a rodent model of athletes heart
Doctor A. Olah (Budapest, HU)
Abstract Slides
Presentation thumbnail
Characterisation of ventricular premature beats during exercise testing in masters athletes
Doctor S. Fyyaz (London, GB)
Abstract Slides
Presentation thumbnail
Determinants of high-risk coronary artery disease in ostensibly healthy male master endurance athletes.
Doctor G. Parry-Williams (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Congress committee e-posters choice in preventive cardiology and special populations

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level
thumbnail
Congress Session
Diabetes, obesity, and heart failure
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources